Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
6/8/15, 6:00 AM
RICHARDSON, TX -- (Marketwired) -- 06/08/15 -- Optex Systems, Inc., a wholly owned subsidiary of Optex Systems Holdings, Inc. (OTCQB: OPXS), a leading manufacturer of optical sighting systems and assemblies for domestic and foreign militaries, announced today they have been awarded 11,200 ACOG Laser Filter Units valued at $1.3M. This award resulted from a successful proposal supplied through the recently acquired Applied Optics Center (AOC) Division and includes an option quantity up-to an additional 11,200 units for a potential contract value of $2.6M.
"This award illustrates that the AOC Division of Optex Systems remains a leading source for laser protection optics to our Department of Defense customers. The key factors for this award rested on our ability to provide the Government with competitive pricing along with our operational capacity to provide high volumes in shorter lead-times," stated Bill Bates, AOC's General Manager. He continued, "We are proud to have been chosen for this award and it clearly demonstrates our organization remains critical as a DoD supplier of laser protection coatings and optical assemblies."
AOC is a key supplier of technically challenging thin-film coatings, optical components, and systems to both DoD and Commercial customers who require a high degree of performance and quality.
6/3/15, 7:03 AM
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) on its novel, self-delivering RNAi platform (sd-rxRNA®). The patent, titled "RNA Interference in Ocular Indications," covers methods of use of RXi's VEGF-targeting and CTGF-targeting self-delivering rxRNAs®, including RXI-109, for use in the eye. The patent, once issued, will be scheduled to expire in 2031.
Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO
This core patent, within RXi's intellectual property portfolio, broadens the coverage of RXi's self-delivering platform and provides coverage of RXI-109 for the treatment of ocular fibrosis. Scarring of the eye, as a consequence of disease or injury, can result in impairment or loss of vision. Medical or surgical treatments for the scarring component of ocular indications is limited. A therapeutic, such as RXI-109, that is effective in reducing the activity of CTGF could have great benefit for patients whose ocular condition has an active scarring component. To date, there are no FDA-approved therapeutics for the treatment and prevention of scarring in the eye.
"We are pleased to receive this notice of allowance from the USPTO, covering the use of our proprietary VEGF and CTGF-targeting sd-rxRNAs in the eye, as RXi prepares to file an IND for the use of RXI-109 to treat ocular fibrosis," said Dr. Geert Cauwenbergh, President and CEO of RXi Pharmaceuticals. He further added, "The Company continues to advance its clinical programs as planned and we look forward to providing additional updates on our ophthalmology and dermatology programs in the coming months."
06/01/15 -- Optex Systems, Inc., a wholly owned subsidiary of Optex Systems Holdings, Inc. (OTCQB: OPXS), a leading manufacturer of optical sighting systems and assemblies for domestic and foreign militaries, announced today a strategic multi-year supply agreement with Nightforce Optics, Inc. (Nightforce) to supply critical optical assemblies through the recently acquired Applied Optics Center (AOC) Division. The targeted amount of goods and services is expected to exceed $6 Million over a multi-year agreement.
"The AOC Division of Optex Systems is proud to have been chosen as a premium supplier to Nightforce. The core competencies of AOC and the manufacturing requirements of Nightforce have aligned to allow both companies to pursue a more strategic relationship within the supply chain," stated Bill Bates, AOC's General Manager. He continued, "This agreement is consistent with our desire to diversify our revenue stream beyond the Department of Defense customer base using existing infrastructure and personnel."
Klaus Johnson, Nightforce's Product and Business Development Manager commented, "We believe this Strategic Supply Agreement with AOC gives Nightforce a competitive edge at a critical time in our business. Our customers demand the absolute best products available and they look to us to bring improved technology and feature sets. This agreement will support Nightforce in delivering on both of those ever increasing demands."
"Most awaited update, EVER!" Said Comic Book Guy...
He's referring to the bid for 450k that showed up Friday.
So, your answer is no.
I ask again: Is there any event that you would interpret as positive, other than the obvious?
And the rising price is the only interest? Increased volume is negative? Is there any event that you would interpret as positive, other than the obvious?
Holy volume, batman!
From Larry's year end letter to shareholders:
"Looking forward, 2015 is the year in which Mantra will showcase a multitude of first-of-their-kind technology demonstrations. This includes two demonstrations of ERC for the production of a suite of valuable chemicals from CO2, and the demonstration MRFC for large-market applications such as backup and stationary power, industrial equipment, and transportation. Because we have based these demonstration projects on the highest quality research and engineering, we expect their success will lead to the company's first early license adoptions this year, catapulting Mantra to the next stage of growth."
The section of text you keep referring to, about it being portable with no mention of a vehicle, is the standard blurb that's been in every pr at the bottom. Why are you taking it out of context and suggesting they've changed their tune? I definitely don't interpret the latest pr in the same way you do. I look forward to their presentation.
Thank you for once again taking the time to thoughtfully respond to these folks. I wouldn't even know where to begin. I always appreciate your posts.
I haven't gotten a notification for the last few press releases... I would guess the website will update soon. My app shows the pr though
175 shares traded to come down 20%-
"I can't even make this stuff up"
First I'm hearing of it
How about the 2.9 million shares shorted after the initial spike early in the day?
So you're long MVTG?
Very interesting. In addition I see Alexy Serov listed as well- very interesting indeed
I'm off this week and happened to be watching when it began- it was wild to see. I agree with your sentiments, and also have to wonder why someone would feel so compelled to put that much money into this without any news. Right?
"The fact that the ERC pilot project has dried-up with Alstom-Lafarge is also an indicator that the commercial version of the technology has not happened."
While I could see this being your inference, there has been absolutely nothing to suggest this is true. While I admit that I really don't know, it makes more sense that delays are BECAUSE of their relationship with these high profile players.
"Irish building supplies groups CRH has agreed to pay 6.5 billion euros ($7.4 billion) for assets that rivals Lafarge and Holcim needed to sell to secure regulatory approval for their planned merger."
That doesn't sound like they're acquiring them, or am I misreading the article?
Now THAT'S funny
And what year is that from?
WITH them?!?!?!?! Please
Hard to believe
They're progressing just fine- great actually. Mistakes- don't you mean successes? Why would anyone who was long mantra interpret things with a glass half empty perspective? Not to mention present ideas to create a glass almost empty perspective?
I think the point was to suggest recent, new dilution when it's kind of old news. At least that's my point. So, no link right?
Is that 10 million is from the spring when the pps soared? That has been discussed a while ago. You make it sound like there's been an additional 10 million. My searching shows as of this month the os is still around 70 mil (70.88). Can you provide a link to show a more recent 10 mil?
Sorry- I see you were asking about the fuel cell. My bad. Still exciting though!
Here's a hint from Larry's year end letter:
"As a result of recent high profile opportunities regarding the deployment and operation of the innovative ERC plant, a comprehensive update on this project will be issued in January."
That's nice. They're taking turns.
More like stripping the shorts off the shorts
Please do! :)
CSTI on the bid and ask, and NITE is up next on both too, with the whopping ask as well. Interesting or just another day?
Picked up another 10,000 at .255 myself...
Yeah- 100,000 share ask from NITE. That's new.
Thanks Eco. I typically let you more knowledgable posters respond to the posts that irk me. Couldn't wait this time.
That situation was 5 years AFTER Larry left that company. How is that relevant?
Sorry- that wasn't you that posted it the first time. Still- why did you leave out the dates?
Once again, Larry left that company 5 years before the situation you're citing. Interesting you left out the dates from this post...